Recursion Pharmaceuticals, Inc. RXRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.47M-81.8% | $35.54M+587% | $5.18M-73.1% | $19.22M+30.4% | $14.75M+224% | ||
| $12.49M-12.5% | $14.28M-2.8% | $14.69M-27.2% | $20.16M-7.6% | $21.83M+70.6% | ||
| -$6.02M-128% | $21.26M+324% | -$9.51M-914% | -$938K+86.8% | -$7.08M— | ||
| -93%-153pp | 59.8%+244pp | -183.8%-179pp | -4.9%+43.2pp | -48%— | ||
| $87.9M-8.4% | $95.94M-20.8% | $121.06M-5.9% | $128.64M-0.8% | $129.63M+31.8% | ||
| $34.59M+2.8% | $33.66M-19.1% | $41.63M-10.8% | $46.65M-14.6% | $54.65M-29.2% | ||
| $134.98M-6.2% | $143.87M-18.9% | $177.38M-9.2% | $195.45M-5.2% | $206.11M+9.5% | ||
| -$128.51M-18.6% | -$108.33M+37.1% | -$172.2M+2.3% | -$176.23M+7.9% | -$191.37M-4.1% | ||
| -1,985.6%-1,681pp | -304.8%+3,023pp | -3,327.6%-2,411pp | -916.8%+381pp | -1,297.9%+2,745pp | ||
| $6.4M+2,657% | $232K-97.7% | $9.95M+130% | $4.33M+138% | -$11.28M-332% | ||
| -$122.11M-13.0% | -$108.1M+33.4% | -$162.25M+5.6% | -$171.9M+15.2% | -$202.65M-13.3% | ||
| -$4.6M— | —— | $3K— | $0+100% | -$158K— | ||
| -$117.5M-8.7% | -$108.12M+33.4% | -$162.25M+5.6% | -$171.9M+15.1% | -$202.49M-13.2% | ||
| -1,815.6%-1,511pp | -304.2%+2,831pp | -3,135.3%-2,241pp | -894.2%+479pp | -1,373.3%+2,562pp | ||
| -$0.22-29.4% | -$0.17+52.8% | -$0.36+12.2% | -$0.41+18.0% | -$0.50+12.3% | ||
| -$108.83M-22.5% | -$88.86M+41.2% | -$151.16M+0.8% | -$152.38M+11.4% | -$172.04M-0.7% | ||
| -1,681.6%-1,432pp | -250%+2,671pp | -2,920.9%-2,128pp | -792.7%+374pp | -1,166.7%+2,591pp | ||
| -$128.51M-18.6% | -$108.33M+37.1% | -$172.2M+2.3% | -$176.23M+7.9% | -$191.37M-4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Recursion Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 7.2% and operating margin is -881.3%, with a -842.9% net margin.
- Where does Recursion Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Recursion Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.